These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22354330)

  • 1. Synthesis and evaluation of radioiodinated phenoxyquinazoline and benzylaminoquinazoline derivatives as new EGF receptor tyrosine kinase imaging ligands for tumor diagnosis using SPECT.
    Hirata M; Kanai Y; Naka S; Matsumuro K; Kagawa S; Yoshimoto M; Ohmomo Y
    Ann Nucl Med; 2012 Jun; 26(5):381-9. PubMed ID: 22354330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A useful EGFR-TK ligand for tumor diagnosis with SPECT: development of radioiodinated 6-(3-morpholinopropoxy)-7-ethoxy-4-(3'-iodophenoxy)quinazoline.
    Hirata M; Kanai Y; Naka S; Yoshimoto M; Kagawa S; Matsumuro K; Katsuma H; Yamaguchi H; Magata Y; Ohmomo Y
    Ann Nucl Med; 2013 Jun; 27(5):431-43. PubMed ID: 23494210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of radioiodinated quinazoline derivative as a new ligand for EGF receptor tyrosine kinase activity using SPECT.
    Hirata M; Kanai Y; Naka S; Matsumuro K; Kagawa S; Yoshimoto M; Ohmomo Y
    Ann Nucl Med; 2011 Feb; 25(2):117-24. PubMed ID: 21058048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expression.
    Yoshimoto M; Hirata M; Kanai Y; Naka S; Nishii R; Kagawa S; Kawai K; Ohmomo Y
    Biol Pharm Bull; 2014; 37(3):355-60. PubMed ID: 24583857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
    Fozing T; Scheuer C; Samnick S
    Eur J Med Chem; 2010 Sep; 45(9):3780-6. PubMed ID: 20538380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiohalogenated 4-anilinoquinazoline-based EGFR-TK inhibitors as potential cancer imaging agents.
    Neto C; Fernandes C; Oliveira MC; Gano L; Mendes F; Kniess T; Santos I
    Nucl Med Biol; 2012 Feb; 39(2):247-60. PubMed ID: 22079040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodination of new EGFR inhibitors as potential SPECT agents for molecular imaging of breast cancer.
    Fernandes C; Oliveira C; Gano L; Bourkoula A; Pirmettis I; Santos I
    Bioorg Med Chem; 2007 Jun; 15(12):3974-80. PubMed ID: 17449254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, biological evaluation, and molecular dynamics (MD) simulation studies of three novel F-18 labeled and focal adhesion kinase (FAK) targeted 5-bromo pyrimidines as radiotracers for tumor.
    Fang Y; Wang D; Xu X; Liu J; Wu A; Li X; Xue Q; Wang H; Wang H; Zhang H
    Eur J Med Chem; 2017 Feb; 127():493-508. PubMed ID: 28109944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: Design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
    Chang J; Ren H; Zhao M; Chong Y; Zhao W; He Y; Zhao Y; Zhang H; Qi C
    Eur J Med Chem; 2017 Sep; 138():669-688. PubMed ID: 28711702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anilinodialkoxyquinazolines: screening epidermal growth factor receptor tyrosine kinase inhibitors for potential tumor imaging probes.
    VanBrocklin HF; Lim JK; Coffing SL; Hom DL; Negash K; Ono MY; Gilmore JL; Bryant I; Riese DJ
    J Med Chem; 2005 Nov; 48(23):7445-56. PubMed ID: 16279804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preclinical evaluation of rhenium and technetium-99m "4 + 1" mixed-ligand complexes bearing quinazoline derivatives as potential EGFR imaging agents.
    Kiritsis C; Shegani A; Makrypidi K; Roupa I; Lazopoulos A; Panagiotopoulou A; Triantopoulou S; Paravatou-Petsotas M; Pietzsch HJ; Pelecanou M; Papadopoulos M; Pirmettis I
    Bioorg Med Chem; 2022 Nov; 73():117012. PubMed ID: 36155319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Synthesis of 4-substituted Quinazolines as Potent EGFR Inhibitors with Anti-breast Cancer Activity.
    Ahmed MF; Magdy N
    Anticancer Agents Med Chem; 2017; 17(6):832-838. PubMed ID: 27671305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors.
    Abourbeh G; Dissoki S; Jacobson O; Litchi A; Ben Daniel R; Laki D; Levitzki A; Mishani E
    Nucl Med Biol; 2007 Jan; 34(1):55-70. PubMed ID: 17210462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel human monoclonal antibody against epidermal growth factor receptor as an imaging probe for hepatocellular carcinoma.
    Sogawa C; Tsuji AB; Yoshida C; Inubushi M; Furukawa T; Koizumi M; Akahori Y; Ukai Y; Kurosawa G; Kurosawa Y; Saga T
    Nucl Med Commun; 2012 Jul; 33(7):719-25. PubMed ID: 22453549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel oxazolo[4,5-g]quinazolin-2(1H)-ones: dual inhibitors of EGFR and Src protein tyrosine kinases.
    Lin J; Shen W; Xue J; Sun J; Zhang X; Zhang C
    Eur J Med Chem; 2012 Sep; 55():39-48. PubMed ID: 22818848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging.
    Tang L; Peng C; Tang B; Li Z; Wang X; Li J; Gao F; Huang L; Xu D; Zhang P; Zhuang R; Su X; Chen X; Zhang X
    J Nucl Med; 2018 Sep; 59(9):1386-1391. PubMed ID: 29653973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.
    Ortu G; Ben-David I; Rozen Y; Freedman NM; Chisin R; Levitzki A; Mishani E
    Int J Cancer; 2002 Oct; 101(4):360-70. PubMed ID: 12209961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of 4-anilinoquinazoline and rhodanine as novel epidermal growth factor receptor tyrosine kinase inhibitors.
    Li SN; Xu YY; Gao JY; Yin HR; Zhang SL; Li HQ
    Bioorg Med Chem; 2015 Jul; 23(13):3221-7. PubMed ID: 26003342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of pyridoquinazoline derivatives as potent epidermal growth factor receptor inhibitors.
    Rani S; Sridhar L; Srivastava R; Singh VK
    Cancer Biother Radiopharm; 2013; 28(6):494-9. PubMed ID: 23641780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.